Group B:Medilac-s capsule

2 trials

Sponsors

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

Conditions

functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)

Phase 4

A multicenter, randomized, controlled, trial for efficacy of Chang-Yan-Ning granules in the treatment of functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)

Active, not recruitingChiCTR2000028830

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang Universityfunctional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)

Start: 2020-01-13Updated: 2020-01-13

A multicenter, randomized, controlled, trial for efficacy of Chang-Yan-Ning granules in the treatment of functional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)

Active, not recruitingITMCTR2000002901

Sir Run Run Shaw Hospital, College of Medicine, Zhejiang Universityfunctional diarrhea (FDi) and diarrhea-predominant irritable bowel syndrome (IBS-D)

Start: 2020-01-13Updated: 2023-02-20

Related Papers

Analysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease

Contrast Media & Molecular Imaging2022-01-0110 citations